GetTopicDetailResponse(id=75b12516efe, topicName=人表皮生長(zhǎng)因子受體2, introduction=人表皮生長(zhǎng)因子受體2, content=null, image=null, comments=3, allHits=1355, url=https://h5.medsci.cn/topic?id=25167, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=37161, tagList=[TagDto(tagId=37161, tagName=人表皮生長(zhǎng)因子受體2)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2244956, encodeId=298a2244956f6, content=<a href='/topic/show?id=c3aa4e516d6' target=_blank style='color:#2F92EE;'>#尿路上皮癌#</a> <a href='/topic/show?id=75b12516efe' target=_blank style='color:#2F92EE;'>#人表皮生長(zhǎng)因子受體2#</a>, objectTitle=【論著】| 中國(guó)尿路上皮癌患者HER2表達(dá)及其與臨床病理學(xué)特征的關(guān)聯(lián)分析, objectType=article, longId=856159, objectId=b15a856159ca, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720666430467_5579292.jpg, objectUrl=/article/show_article.do?id=b15a856159ca, replyNumber=0, likeNumber=64, createdTime=2024-12-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=b15a856159ca, moduleTitle=【論著】| 中國(guó)尿路上皮癌患者HER2表達(dá)及其與臨床病理學(xué)特征的關(guān)聯(lián)分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b15a856159ca)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2209106, encodeId=3f12220910618, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=75b12516efe' target=_blank style='color:#2F92EE;'>#人表皮生長(zhǎng)因子受體2#</a>, objectTitle=European?Radiology：人表皮生長(zhǎng)因子受體2低表達(dá)與過(guò)表達(dá)的乳腺癌亞型MRI鑒別, objectType=article, longId=829511, objectId=ccfd82951170, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240604/1717488133490_5579292.png, objectUrl=/article/show_article.do?id=ccfd82951170, replyNumber=0, likeNumber=137, createdTime=2024-06-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ccfd82951170, moduleTitle=European?Radiology：人表皮生長(zhǎng)因子受體2低表達(dá)與過(guò)表達(dá)的乳腺癌亞型MRI鑒別, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ccfd82951170)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1763361, encodeId=3b031e6336145, content=<a href='/topic/show?id=75b12516efe' target=_blank style='color:#2F92EE;'>#人表皮生長(zhǎng)因子受體2#</a>, objectTitle=J Clin Oncol：輔助紫杉醇和曲妥珠單抗試驗(yàn)治療結(jié)節(jié)陰性、人表皮生長(zhǎng)因子受體2陽(yáng)性乳腺癌的七年隨訪(fǎng)分析, objectType=article, longId=195901, objectId=b90719590192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b90719590192, replyNumber=0, likeNumber=102, createdTime=2020-12-09, rootId=0, userName=ms7517674339485982, userId=2c3037501783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b90719590192, moduleTitle=J Clin Oncol：輔助紫杉醇和曲妥珠單抗試驗(yàn)治療結(jié)節(jié)陰性、人表皮生長(zhǎng)因子受體2陽(yáng)性乳腺癌的七年隨訪(fǎng)分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b90719590192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763360, encodeId=c8801e633607f, content=<a href='/topic/show?id=75b12516efe' target=_blank style='color:#2F92EE;'>#人表皮生長(zhǎng)因子受體2#</a>, objectTitle=Breast Cancer Res Treat：Palbociclib加來(lái)曲唑作為雌激素受體陽(yáng)性/人表皮生長(zhǎng)因子受體2陰性晚期乳腺癌的一線(xiàn)治療效果, objectType=article, longId=195894, objectId=347c195894a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=347c195894a4, replyNumber=0, likeNumber=97, createdTime=2021-03-29, rootId=0, userName=ms7517674339485982, userId=2c3037501783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=347c195894a4, moduleTitle=Breast Cancer Res Treat：Palbociclib加來(lái)曲唑作為雌激素受體陽(yáng)性/人表皮生長(zhǎng)因子受體2陰性晚期乳腺癌的一線(xiàn)治療效果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=347c195894a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763359, encodeId=79781e633594b, content=<a href='/topic/show?id=75b12516efe' target=_blank style='color:#2F92EE;'>#人表皮生長(zhǎng)因子受體2#</a>, objectTitle=2019 CAP指南：乳腺癌人表皮生長(zhǎng)因子受體2免疫組化定量分析, objectType=article, longId=159143, objectId=231c15914303, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=231c15914303, replyNumber=0, likeNumber=75, createdTime=2019-04-18, rootId=0, userName=ms7517674339485982, userId=2c3037501783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=231c15914303, moduleTitle=2019 CAP指南：乳腺癌人表皮生長(zhǎng)因子受體2免疫組化定量分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=231c15914303)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話(huà)題小助手
2020-05-29
